Dados B3 › FRAS3 × EMBJ3
FRAS3 × EMBJ3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | FRAS3 | EMBJ3 | year |
|---|---|---|---|
| ROE | 11.8% | 10.3% | 2025 |
| ROIC | 20.0% | 15.5%! | 2025 |
| ROA | 4.7% | 2.8% | 2025 |
| Gross margin | 32.7% | 17.6% | 2025 |
| EBIT margin | 13.2% | 8.0% | 2025 |
| Net margin | 5.2% | 4.8% | 2025 |
| Net debt/EBITDA | 1.43x | -0.04x | 2025 |
| Current ratio | 2.41x | 1.50x | 2025 |
| Revenue growth (1y) | 38.5% | 18.2% | 2025 |
| Revenue growth (5y CAGR) | 26.9% | 16.4% | 2025 |
| Piotroski F-Score | 4/9 | 8/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | FRAS3 | EMBJ3 | year |
|---|---|---|---|
| P/E | 23.72x | 29.66x | 2025 |
| P/B | 2.67x | 3.06x | 2025 |
| EV/EBITDA | 8.05x | 12.06x | 2025 |
| FCF yield | 20.4% | 3.1% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 15:01 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 15:01 UTC. If this does not match /saude, you are reading a cached copy.